Showing 171-180 of 711 results for "".
Updates on Nitric Oxide As a Topical Anti-infective
https://practicaldermatology.com/topics/practice-management/updates-on-nitric-oxide-as-a-topical-anti-infective/21071/NO continues to show promise as a safe and effective topical treatment candidate for acne and other infectious dermatoses.Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.The Impact of Socioeconomic Status in Atopic Dermatitis and How the Internet Can Act as a Public Health Intervention
https://practicaldermatology.com/youngmd-connect/resident-resource-center/the-impact-of-socioeconomic-status-in-atopic-dermatitis-and-how-the-internet-can-act-as-a-public-health-intervention/23326/2020 In Review
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2020-in-review/23402/Top trends and developments from the yearRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21027/Advancing Sexual Health Histories in Dermatology: A Modernized Comprehensive Approach for Diverse Populations
https://practicaldermatology.com/topics/feature/advancing-sexual-health-histories-in-dermatology-a-modernized-comprehensive-approach-for-diverse-populations/28864/According to the CDC’s 2022 STI Surveillance Report, sexually transmitted infections (STIs) have seen a 1.9% increase in diagnoses over the past five years, underscoring a persistent public health challenge.Curing Z73.89 (a.k.a. Physician Burnout)
https://practicaldermatology.com/topics/practice-management/curing-z7389-aka-physician-burnout/20755/Technology might be the key to finding balance.Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Update on COVID-19 Vaccines and Dermal Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/update-on-covid-19-vaccines-and-dermal-fillers/23451/CSF faculty discuss risks of delayed facial swelling in filler patients following COVID-19 vaccination.Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.